Search Results 221-230 of 24295 for B cell lymphomas
About this study. In this study, participants with relapsed or refractory primary mediastinal large B-cell lymphoma (rrPMBCL) or relapsed or refractory ...
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...
... B cell lymphoma (R/R LBCL). Blood. 2020; doi:10.1182/blood-2020-135988. Ruff MW, Siegler EL, Kenderian SS. A concise review of neurologic complications ...
CAR-T cell therapy may be a treatment option for: Relapsed, refractory B-cell acute lymphoblastic leukemia; Relapsed, refractory B-cell non-Hodgkin's lymphoma ...
Epcoritamab (Epkinly) and glofitamab (Columvi) also target CD3 and CD20 to treat diffuse large B-cell lymphoma (DLBCL) and related lymphomas. Solid tumors.
Related. Appendix cancer · Astrocytoma · Atypical teratoid rhabdoid tumor (ATRT) · Basal cell carcinoma · B-cell lymphoma · Brainstem tumor · Burkitt ...
... B-cell lymphoma, the most common type of non-Hodgkin lymphoma. Understanding who is more likely to have a relapse of lymphoma and why. Finding ways to ...
Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!